Akums Drugs IPO KPI Information
The Akums Drugs IPO KPI (Key Performance Indicators) provide valuable insights into the company's financial efficiency, profitability, and capital utilization. Key metrics such as Return on Equity (ROE), Return on Capital Employed (ROCE), Debt-to-Equity Ratio, Return on Net Worth (RoNW), Price-to-Book Value (P/BV), and PAT Margin help investors evaluate the company's operational performance and financial health before investing in the IPO.
Based on the latest reported financial year (KPI as of March 31, 2024.), Akums Drugs and Pharmaceuticals Limited reported ROE of 0.11%, ROCE of 3.37%, RoNW of -0.57%, PAT Margin of 0.02%, Debt-to-Equity Ratio of 0.69, and Price-to-Book Value (P/BV) of 13.69. These key financial ratios provide investors with a snapshot of the company's profitability, capital efficiency, leverage, and overall financial strength.
Akums Drugs IPO Key Performance Indicators
- Return on Equity (ROE): 0.11%
- Return on Capital Employed (ROCE): 3.37%
- Return on Net Worth (RoNW): -0.57%
- PAT Margin: 0.02%
- Debt-to-Equity Ratio: 0.69
- Price-to-Book Value (P/BV): 13.69
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Akums Drugs and Pharmaceuticals Limited KPI Information
| Particular | KPI as of March 31, 2024. |
|---|---|
| ROE % | 0.11 |
| ROCE % | 3.37 |
| Debt / Equity | 0.69 |
| RoNW % | -0.57 |
| PbW | 13.69 |
| Pat Margin % | 0.02 |
Return Ratio
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Market Cap of Akums Drugs and Pharmaceuticals Limited?
The post-IPO market capitalisation (market cap) of Akums Drugs and Pharmaceuticals Limited is approximately ₹10,685.49 crore, based on the IPO issue price and the company's post-issue equity share capital. Market cap represents the total market value of a company's outstanding shares and is widely used by investors to assess the company's size and valuation.
What is the ROE of Akums Drugs and Pharmaceuticals Limited?
Akums Drugs and Pharmaceuticals Limited reported a Return on Equity (ROE) of 0.11% as of KPI as of March 31, 2024.. ROE measures how efficiently the company generates profits from shareholders' equity. A higher ROE generally indicates strong financial performance and effective management of shareholder funds.
What is the ROCE of Akums Drugs and Pharmaceuticals Limited?
The Return on Capital Employed (ROCE) of Akums Drugs and Pharmaceuticals Limited stood at 3.37% as of KPI as of March 31, 2024.. ROCE measures how efficiently the company uses its total capital to generate profits. A higher ROCE indicates better capital efficiency and operational performance.
What is the Net Profit Margin (PAT Margin) of Akums Drugs and Pharmaceuticals Limited?
Akums Drugs and Pharmaceuticals Limited reported a Profit After Tax (PAT) Margin of 0.02% as of KPI as of March 31, 2024.. PAT Margin shows the percentage of revenue that remains as net profit after all operating expenses, interest, and taxes. A higher margin reflects better profitability and cost management.
What is the Return on Net Worth (RoNW) of Akums Drugs and Pharmaceuticals Limited?
The Return on Net Worth (RoNW) of Akums Drugs and Pharmaceuticals Limited was -0.57% as of KPI as of March 31, 2024.. RoNW measures the company's ability to generate profits from shareholders' net worth and is an important indicator of overall financial efficiency.